Sonoma Pharmaceuticals (O8Z) Stock Forecast & Price Target
O8Z Analyst Ratings
There are no analyst ratings in the last 3 months.
O8Z Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | EUR 1.34→EUR 0.89 | hold | -66.83%Downside | Reiterated | 10/07/26 | ||
| Google Drug Manufacturers - Specialty and Generic | TipRanks - Google | EUR 1.34→EUR 0.89 | hold | -66.83%Downside | Reiterated | 10/07/26 | ||
| Anthropic Drug Manufacturers - Specialty and Generic | TipRanks - Anthropic | EUR 0.89 | sell | -66.83%Downside | Reiterated | 10/07/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | EUR 1.34→EUR 0.89 | hold | -66.83%Downside | Reiterated | 10/07/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | EUR 1.34→EUR 0.89 | hold | -66.83%Downside | Reiterated | 10/07/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | EUR 1.34→EUR 0.89 | hold | -66.83%Downside | Reiterated | 10/07/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | 10/07/26 | EUR 1.34→EUR 0.89 | hold | -66.83%Downside | Reiterated | TipRanks - PerPlexity | ||
| Google Drug Manufacturers - Specialty and Generic | 10/07/26 | EUR 1.34→EUR 0.89 | hold | -66.83%Downside | Reiterated | TipRanks - Google | ||
| Anthropic Drug Manufacturers - Specialty and Generic | 10/07/26 | EUR 0.89 | sell | -66.83%Downside | Reiterated | TipRanks - Anthropic | ||
| OpenAI - Gpt-5.6Sol | 10/07/26 | EUR 1.34→EUR 0.89 | hold | -66.83%Downside | Reiterated | TipRanks - OpenAI | ||
| DeepSeek - V4Pro | 10/07/26 | EUR 1.34→EUR 0.89 | hold | -66.83%Downside | Reiterated | TipRanks - DeepSeek | ||
| xAI - Grok-4.3 | 10/07/26 | EUR 1.34→EUR 0.89 | hold | -66.83%Downside | Reiterated | TipRanks - xAI |
Best Analysts Covering Sonoma Pharmaceuticals
Copying Anthropic Drug Manufacturers - Specialty and Generic's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +2.00% per trade.
Copying Anthropic Drug Manufacturers - Specialty and Generic's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +2.00% per trade.
Copying Anthropic Drug Manufacturers - Specialty and Generic's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +2.00% per trade.
O8Z Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, O8Z has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. O8Z average Analyst price target in the past 3 months is ―.
O8Z Financial Forecast
O8Z Earnings Forecast
Next quarter’s earnings estimate for O8Z is EUR 0.01 with a range of ― to ―. The previous quarter’s EPS was EUR 0.01. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
O8Z Sales Forecast
Next quarter’s sales forecast for O8Z is EUR 5.55M with a range of ― to ―. The previous quarter’s sales results were EUR 5.55M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.